Evidence map›Paper›PMID 18426576›Full record

ArticleJournal of translational medicine2008

Practical aspects in the management of hypokalemic periodic paralysis.

Jacob O Levitt

Erratum issued 4 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03563573 phase1 / phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Single-dose Potassium Supplementation in ADHD Patients With Lidocaine Ineffectiveness

TypeinterventionalSponsorAlkaliDx, Inc.Ran2018 to 2018Enrolled100ConditionsADHDArmsPotassium Gluconate Oral Capsule, Placebo oral capsule
NCT03676725 early_phase1completednot on this mapstarted 2019, after this paper: background citation

Assessing the Frequency of Lidocaine Ineffectiveness in the General Population vs. Males With ADHD, and Females With ADHD, With or Without PMS

TypeinterventionalSponsorPhenoSolve, LLCRan2019 to 2020Enrolled90ConditionsADHD, PMSArmsLidocaine gel
NCT03680885 early_phase1completednot on this mapstarted 2019, after this paper: background citation

Reliability Testing of a Non-invasive, Pain-free, Taste-based Assessment Approach to Lidocaine Effectiveness

TypeinterventionalSponsorPhenoSolve, LLCRan2019 to 2020Enrolled20ConditionsADHD, ControlsArmsLidocaine gel, Placebo, Injected lidocaine
NCT04167189 early_phase1completednot on this mapstarted 2018, after this paper: background citation

Prevalence of Lidocaine Ineffectiveness in Those With Hard-to-treat ADHD

TypeinterventionalSponsorPhenoSolve, LLCRan2018 to 2020Enrolled28ConditionsADHDArmsLidocaine gel
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Lifestyle and dietary measures in Periodic Paralyses.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2026
    Review
  3. Article
  4. Exploring self-management of diet and physical activity inJournal of neuromuscular diseases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Muscle channelopathies: A review.Annals of the Child Neurology Society · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. A Case of Thiazide-induced Hypokalemic Paralysis.Clinical practice and cases in emergency medicine · 2019
    Article
  19. Article
  20. Treatment and management of neuromuscular channelopathies.Current treatment options in neurology · 2014
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Dosage error in article text
5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jacob O Levitt
Mount Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Management considerations in hypokalemic periodic paralysis include accurate diagnosis, potassium dosage for acute attacks, choice of diuretic for prophylaxis, identification of triggers, creating a safe physical environment, peri-operative measures, and issues in pregnancy. A positive genetic test in the context of symptoms is the gold standard for diagnosis. Potassium chloride is the favored potassium salt given at 0.5-1.0 mEq/kg for acute attacks. The oral route is favored, but if necessary, a mannitol solvent can be used for intravenous administration. Avoidance of or potassium prophylaxis for common triggers, such as rest after exercise, high carbohydrate meals, and sodium, can prevent attacks. Chronically, acetazolamide, dichlorphenamide, or potassium-sparing diuretics decrease attack frequency and severity but are of little value acutely. Potassium, water, and a telephone should always be at a patient's bedside, regardless of the presence of weakness. Perioperatively, the patient's clinical status should be checked frequently. Firm data on the management of periodic paralysis during pregnancy is lacking. Patient support can be found at http://www.periodicparalysis.org.

Indexed as

DietDisease ManagementFemaleHumansHypokalemic Periodic ParalysisPotassiumPregnancyPregnancy ComplicationsSelf-Help GroupsPotassium

Identifiers

PMID18426576
PMCPMC2374768
OpenAlexW2038683557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.